Study guide

2.3 Dysrhythmias, Cardiac Arrest, and ACLS

CEN Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: CEN Orientation and Exam Strategy

1.1 Current CEN Exam Facts 1.2 Eligibility, Application, and Scheduling 1.3 Blueprint Domains and Weighting 1.4 Question Style and Score Report Thinking 1.5 Study Calendar and Practice Plan

2 Chapter 2: Cardiovascular Disorders

2.1 Cardiovascular Disorders Overview 2.2 Core Workflows and Decision Points 2.3 Dysrhythmias, Cardiac Arrest, and ACLS 2.4 Shock, Vascular, and Pericardial Emergencies 2.5 Practice Drills and Readiness Markers

3 Chapter 3: Respiratory Disorders

3.1 Respiratory Disorders Overview 3.2 Core Workflows and Decision Points 3.3 Scenario Practice for Respiratory Disorders 3.4 Common Traps in Respiratory Disorders 3.5 Practice Drills and Readiness Markers

4 Chapter 4: Neurological Disorders

4.1 Neurological Disorders Overview 4.2 Core Workflows and Decision Points 4.3 Scenario Practice for Neurological Disorders 4.4 Common Traps in Neurological Disorders 4.5 Practice Drills and Readiness Markers

5 Chapter 5: Gastrointestinal Disorders

5.1 Gastrointestinal Disorders Overview 5.2 Core Workflows and Decision Points 5.3 Scenario Practice for Gastrointestinal Disorders 5.4 Common Traps in Gastrointestinal Disorders 5.5 Practice Drills and Readiness Markers

6 Chapter 6: Genitourinary, Gynecological, and Obstetrical Disorders

6.1 Genitourinary, Gynecological, and Obstetrical Disorders Overview 6.2 Genitourinary Emergencies: Infection, Obstruction, and the Scrotal Clock 6.3 Gynecologic Emergencies and Sexual-Assault Care 6.4 Obstetric Emergencies and Emergency Delivery 6.5 Practice Drills and Readiness Markers

7 Chapter 7: Mental Health Disorders

7.1 Mental Health Disorders Overview 7.2 Core Workflows and Decision Points 7.3 Scenario Practice for Mental Health Disorders 7.4 Common Traps in Mental Health Disorders 7.5 Practice Drills and Readiness Markers

8 Chapter 8: Medical Disorders

8.1 Medical Disorders Overview 8.2 Core Workflows and Decision Points 8.3 Scenario Practice for Medical Disorders 8.4 Common Traps in Medical Disorders 8.5 Practice Drills and Readiness Markers

9 Chapter 9: Musculoskeletal and Wound Disorders

9.1 Musculoskeletal and Wound Disorders Overview 9.2 Core Workflows and Decision Points 9.3 Scenario Practice for Musculoskeletal and Wound Disorders 9.4 Common Traps in Musculoskeletal and Wound Disorders 9.5 Practice Drills and Readiness Markers

10 Chapter 10: Head, Eye, Ear, Nose, and Throat Disorders

10.1 Head, Eye, Ear, Nose, and Throat Disorders Overview 10.2 Core Workflows and Decision Points 10.3 Scenario Practice for Head, Eye, Ear, Nose, and Throat Disorders 10.4 Common Traps in Head, Eye, Ear, Nose, and Throat Disorders 10.5 Practice Drills and Readiness Markers

11 Chapter 11: Environmental, Toxicological, and Communicable Disorders

11.1 Environmental, Toxicological, and Communicable Disorders Overview 11.2 Core Workflows and Decision Points 11.3 Scenario Practice for Environmental, Toxicological, and Communicable Disorders 11.4 Common Traps in Environmental, Toxicological, and Communicable Disorders 11.5 Practice Drills and Readiness Markers

12 Chapter 12: Professional Issues

12.1 Professional Issues Overview 12.2 Core Workflows and Decision Points 12.3 Scenario Practice for Professional Issues 12.4 Common Traps in Professional Issues 12.5 Practice Drills and Readiness Markers

13 Chapter 13: Final Review and Test Day

13.1 Timed Practice Strategy 13.2 Last-Week Review Map 13.3 Exam-Day Checklist 13.4 After the Exam and Next Steps

2.3 Dysrhythmias, Cardiac Arrest, and ACLS

Key Takeaways Explain This Topic AI

VF and pulseless VT are shockable: defibrillate at 200 J biphasic, resume CPR immediately, give epinephrine 1 mg every 3-5 minutes, and amiodarone 300 mg after the third shock.

Asystole and PEA are non-shockable: high-quality CPR plus epinephrine 1 mg every 3-5 minutes while treating reversible causes (the Hs and Ts).

Stable narrow-complex SVT is treated with vagal maneuvers, then adenosine 6 mg rapid IV push followed by 12 mg; unstable tachycardia gets synchronized cardioversion.

Symptomatic bradycardia is treated with atropine 1 mg IV (max 3 mg) per 2020 AHA guidance, then transcutaneous pacing or a dopamine or epinephrine infusion.

Last updated: June 2026

Cardiac Arrest: Shockable vs Non-Shockable

The ACLS arrest algorithms split on one question: is the rhythm shockable? High-quality CPR (push at least 2 inches deep, 100-120 compressions/min, full recoil, minimal interruptions) underlies every pathway.

Shockable rhythms - ventricular fibrillation (VF) and pulseless ventricular tachycardia (pVT):

Defibrillate immediately - 200 J biphasic (or device-specific; 360 J monophasic). Resume CPR right away for 2 minutes; do not pause to check a pulse after the shock.

After the second shock, give epinephrine 1 mg IV/IO every 3-5 minutes .

After the third shock, give amiodarone 300 mg IV/IO (second dose 150 mg), or lidocaine as an alternative.

Non-shockable rhythms - asystole and pulseless electrical activity (PEA):

Do not defibrillate. Provide continuous high-quality CPR and give epinephrine 1 mg every 3-5 minutes as early as possible.

Aggressively search for and treat reversible causes .

Reversible Causes: The Hs and Ts

For PEA and asystole especially, identifying a reversible cause is the difference between return of spontaneous circulation and a failed code.

  • The Hs The Ts
  • H ypovolemia T ension pneumothorax
  • H ypoxia T amponade (cardiac)
  • H ydrogen ion (acidosis) T oxins
  • H ypo-/hyperkalemia T hrombosis, pulmonary (PE)
  • H ypothermia T hrombosis, coronary (MI)

For example, PEA in a dialysis patient suggests hyperkalemia - give calcium, insulin/dextrose, and bicarbonate. PEA with distended neck veins and tracheal deviation suggests a tension pneumothorax needing needle decompression. PEA after chest trauma with muffled heart sounds suggests tamponade needing pericardiocentesis. These cause-specific reversals are favorite CEN distractor sets.

Tachycardia and Bradycardia With a Pulse

Tachycardia (rate > 150) with a pulse: the first question is stability. Signs of instability are hypotension, acutely altered mental status, signs of shock, ischemic chest discomfort, or acute heart failure.

Unstable + tachycardia: perform synchronized cardioversion .

Stable narrow-complex regular (SVT): try vagal maneuvers first (Valsalva, carotid sinus massage), then adenosine 6 mg rapid IV push with a fast saline flush; if no conversion, give 12 mg . Adenosine briefly stops the heart and patients feel a frightening pause.

Atrial fibrillation/flutter with rapid ventricular response: rate control with a calcium channel blocker (diltiazem) or beta-blocker if stable; cardiovert if unstable.

Symptomatic bradycardia: give atropine 1 mg IV (per the 2020 AHA update, increased from 0.5 mg), repeated every 3-5 minutes to a maximum of 3 mg . If atropine fails, start transcutaneous pacing or a dopamine (5-20 mcg/kg/min) or epinephrine (2-10 mcg/min) infusion. Atropine is less effective in high-degree (Mobitz II or third-degree) block, where pacing is the priority.

Reading the Strips: Rhythm Recognition

The CEN shows rhythm strips and expects rapid identification because the rhythm dictates the algorithm. Anchor your recognition on a few discriminators:

Ventricular fibrillation: chaotic, irregular, no identifiable QRS - defibrillate.

Ventricular tachycardia: wide, regular, fast QRS complexes; pulseless VT is defibrillated, while VT with a pulse follows the tachycardia algorithm.

Asystole: a flat line - confirm in two leads and check lead/connection before calling it; never shock asystole.

PEA: an organized rhythm on the monitor with no palpable pulse - the monitor lies, the patient is in arrest.

Atrial fibrillation: irregularly irregular, no discernible P waves.

Atrial flutter: sawtooth flutter waves, often a regular ventricular response.

First-, second- (Mobitz I/II), and third-degree AV block: distinguished by the PR interval and the relationship of P waves to QRS complexes.

A tested trap is confusing fine VF with asystole; if in doubt about a flat-looking rhythm, confirm leads and consider it shockable VF rather than withholding defibrillation.

Post-Cardiac-Arrest Care

After return of spontaneous circulation (ROSC) , the work is not over. The CEN tests the post-arrest bundle:

Optimize oxygenation and ventilation: titrate to an SpO2 of 92-98% and a normal end-tidal CO2; avoid hyperoxia and hyperventilation.

Support hemodynamics: treat hypotension (SBP < 90) with fluids and vasopressors to maintain perfusion.

Obtain a 12-lead ECG: if STEMI is present, emergent coronary angiography is indicated.

Targeted temperature management (TTM): for comatose patients, controlled temperature support improves neurologic outcomes.

Identify and treat the underlying cause (the Hs and Ts) that precipitated the arrest.

These post-ROSC priorities frequently appear as "what is the next step" questions after a successful resuscitation.

Defibrillation versus cardioversion

A classic CEN distinction is defibrillation versus synchronized cardioversion . Defibrillation delivers an unsynchronized shock at full energy and is used for pulseless rhythms (VF and pulseless VT) - there is no organized QRS to synchronize to. Synchronized cardioversion times the shock to the R wave to avoid the vulnerable T-wave period (the R-on-T phenomenon that can induce VF) and is used for unstable tachycardias with a pulse (unstable SVT, atrial fibrillation/flutter, or VT with a pulse).

Pressing "sync" on a pulseless patient wastes time because the machine waits for a QRS that will not come; conversely, defibrillating a perfusing rhythm can provoke VF. Knowing which mode applies to which rhythm is a frequently tested decision point in this domain. A related caveat: polymorphic VT (torsades de pointes) in a pulseless patient is treated like VF with unsynchronized high-energy shocks, because the irregular, varying QRS morphology prevents reliable synchronization - and torsades specifically is treated with IV magnesium sulfate in addition to defibrillation when associated with a prolonged QT interval.